Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Apr 17:13:23.
doi: 10.1186/s13223-017-0194-9. eCollection 2017.

Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor

Affiliations

Regulation of Th2 responses by different cell types expressing the interleukin-31 receptor

Saburo Saito et al. Allergy Asthma Clin Immunol. .

Abstract

Background: Interleukin-31 (IL-31) is a recently identified cytokine produced by Th2 cells that is involved in the development of atopic dermatitis-induced skin inflammation and pruritus. Its receptor, IL-31RA, is expressed by a number of cell types, including epithelial cells, eosinophils, and activated monocytes and macrophages. To date, however, the regulation of Th2 responses by distinct cell types and tissues expressing IL-31RA has not been well studied.

Methods: In this study, Cry j 2, one of the major allergens of Japanese cedar pollen, was administered to IL-31RA-deficient or wild-type (WT) mice via nasal or intraperitoneal injection for induction of specific Th2 responses.

Results: After nasal administration of Cry j 2, IL-31RA-deficient mice showed lower Cry j 2-specific CD4+ T cell proliferation, Th2 cytokine (IL-5 and IL-13) production, and Th2-mediated (IgE, IgG1, and IgG2b) antibody responses than WT mice. In contrast, IL-31RA-deficient mice administered Cry j 2 intraperitoneally showed stronger Th2 immune responses than WT mice.

Conclusions: These results indicate that IL-31R signaling positively regulates Th2 responses induced by nasal administration of Cry j 2, but negatively regulates these responses when Cry j 2 is administered intraperitoneally. Collectively, these data indicate that the induction of antigen-specific Th2 immune responses might depend on tissue-specific cell types expressing IL-31RA.

Keywords: Cry j 2; Deficient mice; IL-31 receptor; IgE; Th2.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Generation of IL-31RA-deficient mice. To generate C57BL/6-IL-31RAtLacZ/+ knock-out (KO) mice, we used homologous recombination in embryonic stem (ES) cells to create a mutant allele in which exon 4 of the IL-31RA gene was replaced by a cassette expressing the selective marker neomycin transferase (a). Two recombinant ES cells were found to be IL-31RAtm1(LacZ). Chimeric mice were mated with C57BL/6 mice to produce mutant IL-31RA+/LacZ(+/−) progeny. The generation of mutant IL-31RA+/− mice was verified by Southern blot analysis (b). The IL-31RA+/− allele was then backcrossed to C57BL/6 mice for 15 more generations using male IL-31RA+/−. Homozygous IL-31RA−/− and WT (IL-31RA+/+) littermates were generated by intercrossing IL-31RA+/− mice from the 15th generations of backcrossed mice. Heterozygous IL-31RA+/− and homozygous IL-31RA−/− littermates were generated by crossing IL-31RA+/− mice with homozygous IL-31RA−/− mice. The expression of IL-31RA or beta-galactosidase of skin from IL-31RA+/+ and IL-31RA−/− mice was revealed by immunohistological staining with antibodies against each antigen (c)
Fig. 2
Fig. 2
IL-31RA−/− mice nasally injected with Cry j 2 exhibit decreased antigen-specific Th2-mediated antibody responses. Serum from WT (IL-31RA+/+, N = 6) and KO (IL-31RA−/−, N = 7) mice following 15 nasal administrations of Cry j 2 was assayed for antigen-specific IgE and IgG1 antibodies (a). Littermate IL-31RA−/− mice (N = 15) and IL-31RA+/− control mice (N = 10) were nasally administered Cry j 2 antigen five times a week for induction of specific Th2 responses. Serum from littermate mice following 15 nasal administrations was assayed for antigen-specific IgE, IgG1, IgG2a, and IgG2b levels (b) by ELISA. The data shown are of one experiment representative of three independent experiments. Data are presented as the mean ± SD. Unpaired t test; *P < 0.05. **P < 0.01
Fig. 3
Fig. 3
IL-31RA−/− mice nasally injected with Cry j 2 show decreased antigen-specific proliferative and Th2 cytokine responses. 7 days after 15 nasal administrations of Cry j 2, spleen cells from WT (IL-31RA+/+, N = 6) and KO (IL-31RA−/−, N = 7) mice were cultured for 88 h in the presence or absence of Cry j 2 (0.1 μg/ml) and pulsed for the last 16 h with 0.5 μCi of tritiated thymidine. The results of T-cell proliferation (a) are expressed in terms of a stimulation index (SI) calculated by dividing counts per minute (cpm) in the presence of antigen with cpm in the absence of antigen. Supernatants obtained from a 72-h cell culture were assayed by ELISA for IL-13 (b) and IL-5 (c). Data are presented as the mean ± SD
Fig. 4
Fig. 4
Decreased antigen-specific proliferative and Th2 cytokine responses of spleen cells from IL-31RA−/− mice nasally injected with Cry j 2. Seven days after 19 nasal administrations of Cry j 2, spleen cells from six representative IL-31RA−/− and littermate control IL-31RA+/− mice were cultured for 88 h in the presence or absence of the indicated dose of Cry j 2 and pulsed for the last 16 h with 0.5 μCi of tritiated thymidine to analyze antigen-specific T-cell proliferative responses (a). Supernatants from 72-h cell cultures were assayed for IL-13 (b) and IL-5 (c). Data are presented as the mean ± SD
Fig. 5
Fig. 5
Decreased antigen-specific Th2 cytokine responses of submandibular lymph node cells from IL-31RA−/− mice nasally injected with Cry j 2. 7 days after 19 nasal administrations of Cry j 2, submandibular lymph node cells from six representative IL-31RA−/− and littermate control IL-31RA+/− mice were pooled and cultured. Supernatants from a 72-h cell culture were assayed by ELISA for IL-5 (a), IL-13 (b), and IFN-γ (c). Data are presented as the mean ± SD
Fig. 6
Fig. 6
IL-31RA−/− mice administered intraperitoneally with Cry j 2 exhibit enhanced antigen-specific Th2-mediated antibody responses. Littermate IL-31RA−/− and IL-31RA+/− control mice were intraperitoneally administered once a week with Cry j 2 for induction of antigen-specific Th2 responses. 7 days after three intraperitoneal administrations of Cry j 2, serum from IL-31RA−/− (N = 5) and littermate control IL-31RA+/− (N = 5) mice were collected and assayed for Cry j 2-specific IgE (a), IgG1 (b), IgG2a (c), and IgG2b (d) antibody responses. Data are presented as the mean ± SD. Unpaired t test; *P < 0.05. Paired t test; #P < 0.05, ##P < 0.01
Fig. 7
Fig. 7
IL-31RA−/− mice intraperitoneally administered Cry j 2 show enhanced antigen-specific proliferative and Th2 cytokine responses. For the analysis of Th2 cytokine responses, spleen cells were collected from mice 7 days after five intraperitoneal administrations of Cry j 2 and cultured with Cry j 2. Supernatants from 72-h cell cultures were assayed for IL-5 (a), IL-13 (b), and IFN-γ (c). The data shown are of one experiment representative of five independent experiments with 4 to 10 mice per group. Data are presented as the mean ± SD

Similar articles

Cited by

References

    1. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004;5(7):752–760. doi: 10.1038/ni1084. - DOI - PubMed
    1. Bilsborough J, Leung DY, Maurer M, Howell M, Boguniewicz M, Yao L, et al. IL-31 is associated with cutaneous lymphocyte antigen-positive skin homing T cells in patients with atopic dermatitis. J Allergy Clin Immunol. 2006;117(2):418–425. doi: 10.1016/j.jaci.2005.10.046. - DOI - PubMed
    1. Ezzat MH, Hasan ZE, Shaheen KY. Serum measurement of interleukin-31 (IL-31) in paediatric atopic dermatitis: elevated levels correlate with severity scoring. J Eur Acad Dermatol Venereol. 2011;25(3):334–339. doi: 10.1111/j.1468-3083.2010.03794.x. - DOI - PubMed
    1. Neis MM, Peters B, Dreuw A, Wenzel J, Bieber T, Mauch C, et al. Enhanced expression levels of IL-31 correlate with IL-4 and IL-13 in atopic and allergic contact dermatitis. J Allergy Clin Immunol. 2006;118(4):930–937. doi: 10.1016/j.jaci.2006.07.015. - DOI - PubMed
    1. Perrigoue JG, Li J, Zaph C, Goldschmidt M, Scott P, de Sauvage FJ, et al. IL-31–IL-31R interactions negatively regulate type 2 inflammation in the lung. J Exp Med. 2007;204(3):481–487. doi: 10.1084/jem.20061791. - DOI - PMC - PubMed